I'm LongbridgeAI, I can summarize articles.Vertex Pharmaceuticals has appointed Debanjan Saha as a Class II Director, effective October 7, 2026. The appointment follows a recommendation by the Nominating and Governance Committee. Saha currently serves as CEO of DataRobot and holds previous leadership roles at Google Cloud and AWS.
Vertex appointed Debanjan Saha as a Class II director, effective October 7, 2026.
| Individual | Debanjan Saha |
| Role | Class II Director |
| Type of Change | Appointed / Elected |
| Effective Date | October 7, 2026 |
| Reason | Board election upon recommendation of the Nominating and Governance Committee |
| Replacement Info | Not disclosed |
| Background Details | CEO of DataRobot since Sept 2022; prior VP/GM roles at Google Cloud and AWS; MS, PhD (Univ. of Maryland); B.Tech IIT Kharagpur; IEEE Fellow; ACM distinguished member |
| Board/Committee Role Changes | Has not yet been named to any committees |
Original SEC Filing: Vertex, Inc. [ VERX ] - 8-K - Oct. 01, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.